Lumira Ventures Fund V

About Lumira Ventures Fund V

Lumira Ventures hits first close on US$200M Fund V to champion North American healthcare innovation. Invests in healthcare, biotech, and digital health companies at Series A and B.

Investment Focus

Location / RegionCanada

Funding StageSeries A

Industry Focus

Biotech

Digital Health

Therapeutics

Investor Signals Profile

active

Sweet Spot

Pre-commercial biotech/medtech founder in underserved NA market

biotech

medtech

North America secondary markets

rare disease

radiopharmaceuticals / autoimmune

neuromodulation / chronic pain

Bullish Signals

First close done, $52M deal deployedblog

7 exits >$8B since 2024blog

Anchor LP Northleaf returningblog

Structured succession, next-gen team builtblog

Fusion Pharma exit $2.4B AstraZenecatwitter

Co-led $105M Series A, COUR Pharmatwitter

Portfolio FDA approvals: Cordella, X4, Histosonicstwitter

Suman Rao promoted Principal Jan 2025twitter

Fund V first deal: Nervonik $52.5M Series Blinkedin

Neuromodulation/chronic pain added to thesislinkedin

Contrarian Signals

26% of fund in single dealblog

Canadian commercialization path lags USblog

First investment undisclosed — limited transparencyblog

Large syndicate rounds — smaller ownership stakestwitter

Founder Do's

Build in secondary NA markets (not Boston/SF/NY)

Be pre-commercial with strong clinical data

Have clear strategic acquirer landscape

Show capital efficiency discipline

Target rare disease, autoimmune, or neuromodulation

Founder Don'ts

Expect passive capital — board-level engagement standard

Pitch without regulatory pathway clarity

Assume coastal-only fund coverage

Key GPs & Partners

Gerry Brunk

Managing Partner

hands-onthesis-drivenex-founder

Peter van der Velden

Executive Chairman

patient-capitalcommunity-builder

Isabelle Harris

Associate

thesis-driven

Suman Rao

Principal

thesis-drivencommunity-builder

Nikhil Thatte

Senior Principal

thesis-driven

Unlock Investor Signals

$29/month for full signal access. Cancel anytime.

View Plans Browse all Signal Profiles →

Fund Overview

Fund Size$200M

Saves0

Website

Key People

Peter van der Velden

Gerry BrunkManaging Partner

Peter van der VeldenExecutive Chairman

Isabelle HarrisAssociate

Suman RaoPrincipal

Nikhil ThatteSenior Principal